Influence of β-catenin small interfering RNA on human osteosarcoma cells

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 31, Issue 3, 2011, Pages 353-358

  Zhang, Fan ^a   Chen, Anmin ^a   Chen, Jianfeng ^a   Yu, Tian ^b   Guo, Fengjing ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Wuhan Aier Eye Hospital   (China)

Author keywords

catenin; osteosarcoma; siRNA; gene therapy

Indexed keywords

BETA CATENIN; CTNNB1 PROTEIN, HUMAN; MATRIX METALLOPROTEINASE 14; MMP14 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ARTICLE; BONE TUMOR; CANCER INVASION; CELL MOTION; DOWN REGULATION; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; METASTASIS; OSTEOSARCOMA; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

BETA CATENIN; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MATRIX METALLOPROTEINASE 14; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OSTEOSARCOMA; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 80455167875     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-011-0380-9     Document Type: Article

References (25)

1. Broadhead ML, Clark JC, Choong PF, et al. Making gene therapy for osteosarcoma a reality. Expert Rev Anticancer Ther, 2010,10(4):477-480
2. Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus. Science, 2000,287(5458):1606-1609 (Pubitemid 30127755)
3. Hoang BH, Kubo T, Healey JH, et al. Expression of LDL receptor-related protein 5 (LRP5) as a novel marker for disease progression in high-grade osteosarcoma. Int J Cance, 2004,109(1):106-111 (Pubitemid 38160669)
4. Guo Y, Rubin EM, Xie J, et al. Dominant negative LRP5 decreases tumorigenicity and metastasis of osteosarcoma in an animal model. Clin Orthop Relat Res, 2008,466(9):2039-2045
5. Guo Y, Zi X, Koontz Z, et al. Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells. J Orthop Res, 2007,25(7):964-971 (Pubitemid 47046444)
6. Haydon RC, Deyrup A, Ishikawa A, et al. Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma. Int J Cancer, 2002,102(4):338-342 (Pubitemid 35265873)
7. Yang F, Zeng Q, Yu G, et al. Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC. Cell Signal, 2006,18(5): 679-687 (Pubitemid 43113298)
8. Iwaya K, Ogawa H, Kuroda M, et al. Cytoplasmic and/or nuclear staining of beta-catenin is associated with lung metastasis. Clin Exp Metastasis, 2003,20(9): 525-529 (Pubitemid 37297180)
9. Iwoa K, Miyoshi Y, Nawa G, et al. Frequent beta-catenin abnormalities in bone and soft-tissue tumors. Jpn J Cancer Res, 1999,90(2):205-209 (Pubitemid 29112321)
10. Cai Y, Mohseny AB, Karperien M, et al. Inactive Wnt/II-catenin pathway in conventional high-grade osteosarcoma. J Pathol, 2010,220(1):24-33
11. Reynolds A, Leake D, Boese Q, et al. Rational siRNA design for RNA interference. Nat Biotechnol, 2004,22(3):326-330 (Pubitemid 38295766)
12. Hajra KM, Fearon ER. Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer, 2002,34(3):255-268 (Pubitemid 34553304)
13. Polakis P. Wnt signaling and cancer. Genes Dev, 2000,14(15):1837-1851 (Pubitemid 30639518)
14. Verma UN, Surabhi RM, Schmaltieg A, et al. Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin Cancer Res, 2003,9(4):1291-300 (Pubitemid 36418379)
15. Zeng G, Apte U, Cieply B, et al. siRNA-mediated β-catenin knockdown in human hepatoma cells results in decreased growth and survival. Neoplasia, 2007,9(11):951-959 (Pubitemid 350086440)
16. Pu P, Zhang Z, Kang C, et al. Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth. Cancer Gene Ther, 2009,16(4):351-361
17. Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nature Rev Cancer, 2008,8(5): 387-398 (Pubitemid 351589714)
18. Chen K, Fallen S, Abaan HO, et al. Wnt10b induces chemotaxis of osteosarcoma and correlates with reduced survival. Pediatr Blood Cancer, 2008,51(3):349-355
19. Hoang BH, Kubo T, Healey JH, et al. Dickkopf 3 inhibits invasion and motility of saos-2 osteosarcoma cells by modulating the wnt-beta-catenin pathway. Cancer Res, 2004,64(8):2734-2739 (Pubitemid 38500609)
20. Seiki M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett, 2003,194(1): 1-11 (Pubitemid 36428879)
21. Zucker S, Pei D, Cao J, et al. Membrane type-matrix metalloproteinases (MT-MMP). Curr Top Dev Biol, 2003,54:1-74 (Pubitemid 137639464)
22. Daino K, Ugolin N, Altmeyer-Morel S, et al. Gene expression profiling of alpha-radiation-induced rat osteosarcomas: identification of dysregulated genes involved in radiationinduced tumorigenesis of bone. Int J Cancer, 2009,125(3):612-620
23. Leow PC, Tian Q, Ong ZY, et al. Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/II-catenin antagonists against human osteosarcoma cells. Invest New Drugs, 2010,28(6):766-782
24. Kansara M, Tsang M, Kodjabachian L, et al. Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice. J Clin Invest, 2009,119(4): 837-851
25. Thomas DM. Wnts, bone and cancer. J Pathol, 2010,220(1):1-4